Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Tables)

v3.21.2
STOCKHOLDERS’ EQUITY (Tables)
 3 Months Ended
Sep. 30, 2021
Equity [Abstract]  
SCHEDULE OF STOCK WARRANT ACTIVITY

Warrant detail for the three months ended September 30, 2021 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2021     214,883     $ 4.49       2.92  
Warrants issued     1,071,430     $ 7.00       5.00  
Warrants outstanding at September 30, 2021     1,286,313     $ 6.58       4.61  
Warrants exercisable at September 30, 2021     968,670     $ 6.44       4.48  

 

Warrant detail for the three months ended September 30, 2020 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2020     83,205     $ 4.00       2.01  
Warrants issued     185,955     $ 4.80       5.00  
Warrants outstanding at September 30, 2020     269,160     $ 4.55       3.91  
Warrants exercisable at September 30, 2020     83,205     $ 4.00       1.76  
SCHEDULE OF STOCK OPTIONS ACTIVITY

Activity in the Company’s stock options during the three months ended September 30, 2021 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining Contract Term

(# years)

  
Outstanding at June 30, 2021     531,205     $ 11.02       6.73  
Granted     -     $ -       -  
Exercised     (3,400 )   $ 4.65       -  
Forfeited and cancelled     (2,626 )   $ 13.60       -  
Outstanding at September 30, 2021     525,179     $ 11.05       6.32  
Exercisable at September 30, 2021     499,533     $ 10.97       6.25  

 

Activity in the Company’s stock options during the three months ended September 30, 2020 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining Contract Term

(# years)

  
Outstanding at June 30, 2020     579,584     $ 11.00       7.55  
Granted     -     $ -       -  
Exercised     -     $ -       -  
Forfeited and cancelled     (1,751 )   $ 13.60       -  
Outstanding at September 30, 2020     577,833     $ 10.99       7.22  
Exercisable at September 30, 2020     482,300     $ 10.79       6.99  
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

Activity in RSUs during the three months ended September 30, 2021 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Grant date Fair Value    

Weighted Average Remaining Contract Term

(# years)

  
Outstanding at June 30, 2021     131,652     $ 9.25       2.72  
Granted     -     $ -       -  
Forfeited and cancelled     (4,683 )   $ 8.88       -  
Outstanding at September 30, 2021     126,969     $ 9.26       2.59  
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES

The following table summarizes stock-based compensation expense for employee and non-employee option and RSU grants:

 

    Three Months Ended
September 30,		  
    2021     2020  
Research and development   $ 36,000     $ 53,000  
Selling and administrative     164,000       172,000  
Total stock-based compensation expense   $ 200,000     $ 225,000